Related references
Note: Only part of the references are listed.TRIP13 regulates DNA repair pathway choice through REV7 conformational change
Connor S. Clairmont et al.
NATURE CELL BIOLOGY (2020)
Radiation resistance in head and neck squamous cell carcinoma: dire need for an appropriate sensitizer
Marsha-Kay N. D. Hutchinson et al.
ONCOGENE (2020)
TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status
Sumit Agarwal et al.
MOLECULAR ONCOLOGY (2020)
Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growth
Lulu Hu et al.
CANCER LETTERS (2020)
Investigational multitargeted kinase inhibitors in development for head and neck neoplasms
Ana Marija Sola et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
Cell-penetrating peptide sequence and modification dependent uptake and subcellular distribution of green florescent protein in different cell lines
Sanjay G. Patel et al.
SCIENTIFIC REPORTS (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Maura L. Gillison et al.
LANCET (2019)
Increased expression of TRIP13 drives the tumorigenesis of bladder cancer in association with the EGFR signaling pathway
Yanjun Gao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Nonhomologous DNA end-joining for repair of DNA double-strand breaks
Nicholas R. Pannunzio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP Inhibitors
Leslie A. Parsels et al.
MOLECULAR CANCER RESEARCH (2018)
Deep mutational analysis reveals functional trade-offs in the sequences of EGFR autophosphorylation sites
Aaron J. Cantor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
The pendulum of the Ku-Ku clock
Atsushi Shibata et al.
DNA REPAIR (2018)
Using immunotherapy to boost the abscopal effect
Wilfred Ngwa et al.
NATURE REVIEWS CANCER (2018)
The molecular landscape of head and neck cancer
C. Rene Leemans et al.
NATURE REVIEWS CANCER (2018)
Non-homologous DNA end joining and alternative pathways to double-strand break repair
Howard H. Y. Chang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Systematic review of case reports on the abscopal effect
Yazan Abuodeh et al.
CURRENT PROBLEMS IN CANCER (2016)
Targeting pathways mediating resistance to anti-EGFR therapy in squamous cell carcinoma of the head and neck
Nicholas P. Campbell et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2016)
Negative Selection and Chromosome Instability Induced by Mad2 Overexpression Delay Breast Cancer but Facilitate Oncogene-Independent Outgrowth
Konstantina Rowald et al.
CELL REPORTS (2016)
Pch2TRIP13: controlling cell division through regulation of HORMA domains
Gerben Vader
CHROMOSOMA (2015)
The Ku heterodimer: Function in DNA repair and beyond
Victoria L. Fell et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2015)
Impact of retropharyngeal adenopathy on distant control and survival in HPV-related oropharyngeal cancer treated with chemoradiotherapy
Stuart E. Samuels et al.
RADIOTHERAPY AND ONCOLOGY (2015)
TRIP13 is a protein-remodeling AAA plus ATPase that catalyzes MAD2 conformation switching
Qiaozhen Ye et al.
ELIFE (2015)
Induction and Processing of the Radiation-Induced Gamma-H2AX Signal and Its Link to the Underlying Pattern of DSB: A Combined Experimental and Modelling Study
Francesco Tommasino et al.
PLOS ONE (2015)
Current challenges and clinical investigations of epidermal growth factor receptor (EGFR)- and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma (HNSCC)
Roger B. Cohen
CANCER TREATMENT REVIEWS (2014)
A Secreted Tyrosine Kinase Acts in the Extracellular Environment
Mattia R. Bordoli et al.
CELL (2014)
Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522
K. Kian Ang et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer
Rajat Banerjee et al.
NATURE COMMUNICATIONS (2014)
Elucidating Human Phosphatase-Substrate Networks
Xun Li et al.
SCIENCE SIGNALING (2013)
Mechanics of EGF Receptor/ErbB2 kinase activation revealed by luciferase fragment complementation imaging
Jennifer L. Macdonald-Obermann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Molecular targeted therapies in all histologies of head and neck cancers: an update
Albiruni R. A. Razak et al.
CURRENT OPINION IN ONCOLOGY (2010)
GENOTYPING OF 73 UM-SCC HEAD AND NECK SQUAMOUS CELL CARCINOMA CELL LINES
J. Chad Brenner et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2010)
Enhanced H2AX Phosphorylation, DNA Replication Fork Arrest, and Cell Death in the Absence of Chk1
Mary E. Gagou et al.
MOLECULAR BIOLOGY OF THE CELL (2010)
Targeting Nonhomologous End-Joining Through Epidermal Growth Factor Receptor Inhibition: Rationale and Strategies for Radiosensitization
Bipasha Mukherjee et al.
SEMINARS IN RADIATION ONCOLOGY (2010)
Human Protein Reference Database-2009 update
T. S. Keshava Prasad et al.
NUCLEIC ACIDS RESEARCH (2009)
Understanding and re-engineering nucleoprotein machines to cure human disease
William Dynan et al.
NANOMEDICINE (2008)
Recent advances in head and neck cancer
Robert I. Haddad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Phase II study of combination cetuximab and weekly paclitaxel in patients with metastatic/recurrent squamous cell carcinoma of head and neck (SCCHN): Spanish Head and Neck Cancer Group (TTCC)
R. Hitt et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy
Jan B. Vermorken et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications
Michel Zimmermann et al.
RADIATION ONCOLOGY (2006)
Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft
FR Luo et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase
K Dittmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity
K Dittmann et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Rap1A and rap1B ras-family proteins are prominently expressed in the nucleus of squamous carcinomas: nuclear translocation of GTP-bound active form
RS Mitra et al.
ONCOGENE (2003)
Share Paper
